Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
B1673 BenzbromaroneSummary: TMEM16A/B calcium-activated chloride channel (CaCC) blocker -
B1674 Benzethonium ChlorideSummary: Potent inhibitor of nAChRs -
B1677 Benzydamine HClSummary: Topical nonsteroidal anti-inflammatory drug (NSAID) -
B1693 Cetrimonium Bromide (CTAB)Summary: Component of the broad-spectrum antiseptic cetrimide -
B1695 Chlorhexidine HClSummary: Antiseptic -
B1698 ChlorquinaldolSummary: Antifungal and antibacterial -
B1701 ChlorzoxazoneSummary: Muscle-relaxing drug -
B1709 Clodronate DisodiumSummary: Potent antiosteolytic agent -
B1710 ClofazimineSummary: Tuberculosis drug -
B1921 Cyclamic acidSummary: artificial sweetening agent


